tert-butyl (4R)-4-amino-3,3-difluoropiperidine-1-carboxylate, 100mg

2,3,5-Triiodobenzoic Acid>98.0%(HPLC)(T)25g

1-(2,2-difluoroethyl)-1H-pyrazole-3-carboxylic acid, 95.0%, 100mg

3-(3-Pyridin-3-yl-[1,2,4]oxadiazol-5-yl)-propionic acid, 97.0%, 10g

PARAXANTHINE, 95%, 250mg

n-Octyl Sulfide>97.0%(GC)100g

2-Phenyl-1H-indol-5-amine, 95.0%, 100mg

N-[(1R,2R)-2-Amino-1,2-bis(4-methoxyphenyl)ethyl]4-methylbenzenesulfonamide, 97%, 5g

Quinoxaline-2(1h)-thione, 98%, 10g

2-Methyl-4-trifluoromethyl-thiazole-5-carbonyl chloride, 95.0%, 5g

(R)-2-Phenyl-2-(((2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-((((2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)methyl)tetrahydro-2H-pyran-2-yl)oxy)acetonitrile, 95%, 1g

n-Pentane, minimum 95 %, le plus pur, 5 l, aluminium

4-(2-bromoethyl)-4H-1,2,4-triazole hydrobromide, 95.0%, 250mg